Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                First Generic Drug Approvals

First Generic Drug Approvals

                        ANDA (Generic) Drug Approvals - Previous Years Home
          Drugs
          Development & Approval Process | Drugs
          How Drugs are Developed and Approved
          Drug and Biologic Approval and IND Activity Reports
          First Generic Drug Approvals
          ANDA (Generic) Drug Approvals - Previous YearsFirst Generic Drug Approvals ANDA (Generic) Drug Approvals - Previous Years
  
  	
    Share
    Post
    Linkedin

    Email
    PrintEach year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for patients.

“First generics” are just what they sound like—the first approval by FDA which permits a manufacturer to market a generic drug product in the United States. FDA considers first generics to be important to public health, and prioritizes review of these submissions.

First Generic Drug Approvals - Previous Years

2022 First Generic Drug Approvals
	2021 First Generic Drug Approvals
	2020 First Generic Drug Approvals
	2019 First Generic Drug Approvals
	2018 First Generic Drug Approvals
	2017 First Generic Drug Approvals
	2016 First Generic Drug Approvals
	2001-2015 ANDA approvals are archived. To view them, please see the FDA Archive

ANDA (Generic) Drug Approvals - Previous Years

ANDA (Generic) Drug Approvals in 2016

                                                                                  Content current as of:
      02/10/2022First Generic Drug Approvals

          
                        ANDA (Generic) Drug Approvals - Previous Years
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop